| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.247 | 1.909 | 2.890 | 1.031 | 2.234 | 4.590 | 7.884 | 5.516 | 8.895 | 8.443 |
| Total Income - EUR | 5.247 | 1.909 | 2.890 | 1.031 | 2.234 | 4.590 | 7.927 | 10.674 | 11.502 | 8.443 |
| Total Expenses - EUR | 17.423 | 5.911 | 4.748 | 6.609 | 6.937 | 6.827 | 6.619 | 7.127 | 20.975 | 8.798 |
| Gross Profit/Loss - EUR | -12.176 | -4.002 | -1.859 | -5.578 | -4.704 | -2.237 | 1.308 | 3.547 | -9.473 | -355 |
| Net Profit/Loss - EUR | -12.333 | -4.059 | -1.945 | -5.608 | -4.771 | -2.372 | 1.070 | 3.227 | -9.473 | -355 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medicorx S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 48.501 | 46.372 | 43.980 | 41.596 | 39.332 | 37.198 | 35.016 | 33.764 | 33.785 | 31.920 |
| Current Assets | 51.307 | 48.820 | 47.579 | 41.270 | 37.528 | 38.099 | 39.110 | 41.335 | 33.409 | 31.721 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 51.223 | 48.851 | 47.480 | 40.270 | 37.352 | 38.136 | 38.136 | 39.480 | 26.436 | 25.470 |
| Cash | 83 | -31 | 99 | 1.000 | 176 | -37 | 974 | 1.854 | 6.973 | 6.252 |
| Shareholders Funds | 24.048 | 19.743 | 17.464 | 11.535 | 6.541 | 4.045 | 5.026 | 8.268 | -2.571 | -2.912 |
| Social Capital | 40.495 | 40.082 | 39.404 | 38.681 | 37.931 | 37.212 | 36.387 | 36.500 | 36.389 | 36.186 |
| Debts | 75.760 | 75.449 | 74.096 | 71.331 | 70.318 | 71.252 | 69.100 | 66.830 | 69.765 | 66.553 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Medicorx S.a.